Evidence map›Paper›PMID 32595830›Full record

ArticleOncotarget2020

Preliminary safety and imaging efficacy of the near-infrared fluorescent contrast agent DA364 during fluorescence-guided surgery in dogs with spontaneous superficial tumors.

Sophie Favril, Chiara Brioschi, Katrien Vanderperren, Eline Abma, Emmelie Stock, Nausikaa Devriendt, Ingeborgh Polis, Hilde De Cock, Alessia Cordaro, Luigi Miragoli and 8 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Evaluation of a targeted anti-αEuropean journal of nuclear medicine and molecular imaging · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 3 countries.

Sophie Favril *Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Chiara Brioschi *Bracco Imaging SpA, c/o BioIndustry Park, Colleretto Giacosa, Italy.
Katrien VanderperrenDepartment of Veterinary Medical Imaging and Small Animal Orthopaedics, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Eline AbmaSmall Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Emmelie StockDepartment of Veterinary Medical Imaging and Small Animal Orthopaedics, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Nausikaa DevriendtSmall Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Ingeborgh PolisSmall Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Hilde De CockMedvet/Algemeen Medisch Laboratorium, Antwerpen, Belgium.
Alessia CordaroBracco Imaging SpA, c/o BioIndustry Park, Colleretto Giacosa, Italy.
Luigi MiragoliBracco Imaging SpA, c/o BioIndustry Park, Colleretto Giacosa, Italy.
Paolo OlivaBracco Imaging SpA, c/o BioIndustry Park, Colleretto Giacosa, Italy.
Giovanni ValbusaEphoran Multi-Imaging Solutions, Colleretto Giacosa, Italy.
Charline AlleaumeBracco Suisse S.A., Plan-les-Ouates, Switzerland.
Isabelle TardyBracco Suisse S.A., Plan-les-Ouates, Switzerland.
Alessandro MaiocchiBracco Imaging SpA, c/o BioIndustry Park, Colleretto Giacosa, Italy.
Fabio TedoldiBracco Imaging SpA, c/o BioIndustry Park, Colleretto Giacosa, Italy.
Francesco Blasi *Bracco Imaging SpA, c/o BioIndustry Park, Colleretto Giacosa, Italy.
Hilde de Rooster *Small Animal Department, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.
Bracco (Italy) · ITGhent University · BEBracco (Switzerland) · CHMédecins du Monde · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor-targeting contrast agents may facilitate resection of solid neoplasms during fluorescence-guided surgery. Preliminary safety and imaging efficacy of the near-infrared fluorescent probe DA364 were evaluated during surgical resection of spontaneous solid tumors in 24 dogs. Intra-operative imaging was performed

Indexed as

caninefluorescence-guided surgeryfluorescent contrast agentnear-infrared fluorescence imagingspontaneous tumors

Identifiers

PMID32595830
PMCPMC7299531
OpenAlexW3036325460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.